Syrian Democratic Forces & Gilead Sciences

Syrian Democratic Forces: The Syrian Democratic Forces, a rebel group allied with the Islamic State group, has carried out violent attacks in Democratic Republic of the Congo — Ituri Province, killing civilians and burning homes, further complicating Ebola containment efforts.

Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.

Syrian Democratic Forces: The Syrian Democratic Forces' violence in Democratic Republic of the Congo — Ituri Province further complicates the response to the Ebola outbreak by creating an unstable environment.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Syrian Democratic Forces: The Syrian Democratic Forces, an armed group with ties to the Islamic State, has attacked civilians in Ituri, adding to the region's volatility and hindering Ebola response efforts.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.